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Background—Abdominal adiposity is a growing clinical and public health problem. It is not known whether it is similarly
associated with cardiovascular disease (CVD) and diabetes mellitus in different regions around the world, and thus whether
measurement of waist circumference (WC) in addition to body mass index (BMI) is useful in primary care practice.
Methods and Results—Randomly chosen primary care physicians in 63 countries recruited consecutive patients aged 18
to 80 years on 2 prespecified half days. WC and BMI were measured and the presence of CVD and diabetes mellitus
recorded. Of the patients who consulted the primary care physicians, 97% agreed to participate in the present study.
Overall, 24% of 69 409 men and 27% of 98 750 women were obese (BMI30 kg/m2). A further 40% and 30% of men
and women, respectively, were overweight (BMI 25 to 30 kg/m2). Increased WC (102 for men and 88 cm for
women) was recorded in 29% and 48%, CVD in 16% and 13%, and diabetes mellitus in 13% and 11% of men and
women, respectively. A statistically significant graded increase existed in the frequency of CVD and diabetes mellitus
with both BMI and WC, with a stronger relationship for WC than for BMI across regions for both genders. This
relationship between WC, CVD, and particularly diabetes mellitus was seen even in lean patients (BMI25 kg/m2).
Conclusions—Among men and women who consulted primary care physicians, BMI and particularly WC were both
strongly linked to CVD and especially to diabetes mellitus. Strategies to address this global problem are required to
prevent an epidemic of these major causes of morbidity and mortality. (Circulation. 2007;116:1942-1951.)
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The beneficial impact on cardiovascular morbidity andmortality of favorable trends in population control of
classic risk factors such as smoking, hypercholesterolemia,
and hypertension may be reversed by the current epidemic of
obesity.1–6 Obesity, in particular abdominal adiposity, is
associated with increased risk of cardiovascular disease
(CVD) and diabetes mellitus.7–22 The prevalence of diabetes
mellitus is increasing,23 and already in the United States the
lifetime risk of developing diabetes mellitus is high: 33% for
men and 38% for women.24 Given that patients with diabetes
mellitus have at least a 2-fold higher risk of cardiovascular
mortality than nondiabetic patients,25 obesity has become a
major clinical and public health problem that threatens to
overwhelm already extended healthcare services in many
countries.
Clinical Perspective p 1951
Recent publications have shown that the overweight and
particularly the obese have progressively higher morbidity
and mortality.26,27 The multinational INTERHEART case-
control study confirmed the importance of obesity, particu-
larly abdominal adiposity, as a potent risk factor for myocar-
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dial infarction.15,16 Despite this interest, worldwide data on
the distribution of even simple measures such as waist
circumference (WC), made with a standardized protocol, are
not available. This is crucial if geographic or ethnic thresh-
olds are to be established for interventional programs. It is
also important to extend the INTERHEART observations to
determine the impact of adiposity on CVD and diabetes
mellitus in different regions of the world and in a more widely
based population that consults primary care physicians
(PCPs).
The International Day for Evaluation of Abdominal obesity
(IDEA)28 was a large, international, noninterventional, cross-
sectional study to evaluate abdominal adiposity (WC) mea-
sured by a standardized protocol in 168 000 primary care
patients on 2 prespecified half-days in 63 countries. This
report describes the geographic distribution of WC, over-
weight, and obesity, and evaluates whether WC in addition to
body mass index (BMI) is a useful clinical marker of
physician-reported CVD and diabetes mellitus.
Methods
Between May 9 and July 6, 2005, all consecutive patients aged 18 to
80 years who consulted the randomly selected PCPs for any reason
were invited to participate in the present study, on 2 half-days
prespecified for each of the 63 countries.28 Women who were known
to be pregnant were excluded.
Physicians recorded each patient’s age, gender, smoking status,
presence of known CVD (defined on the form as coronary heart
disease, stroke, or revascularization), and known diabetes mellitus
(type 1 or type 2). Disease status used a combination of the
physician’s knowledge of the patient’s history, medical notes, and
patient recall. The PCPs were trained to measure WC in the standing
position, midway between the lowest rib and the iliac crest.1 Weight
and height were measured, and BMI was calculated. Ethics commit-
tee approval was obtained for each participating site and each patient
provided written informed consent.
A sample size of 1100 patients per country enabled the fre-
quency of abdominal obesity (with any definition) to be estimated to
within 3% with 95% confidence. PCPs were randomly selected in
each country by geographic or administrative strata from an exhaus-
tive list of active PCPs, as reported previously,28 to ensure that
participants in the present study were representative of PCP patients.
Statistical Analysis
Data from 63 countries were grouped into 11 regions. Patient
characteristics are described by percentages, means, and SD. Re-
gional frequencies of obesity (BMI30 kg/m2), overweight (BMI 25
to 30 kg/m2), CVD, and diabetes mellitus were standardized accord-
ing to the age distribution of the overall study population. Box-and-
whisker plots describe regional distributions of WC (median, quar-
tiles). Age- and region-adjusted frequencies of CVD and diabetes
mellitus were calculated according to gender-specific WC quintiles
with logistic regression in PROC GENMOD (SAS Institute, Cary,
NC) with age as a continuous variable. Age- and region-adjusted
odds ratios (ORs) were calculated according to the thresholds
defined by the National Cholesterol Education Program Adult
Treatment Panel III (NCEP)29 and the International Diabetes Feder-
ation (IDF)30 for WC, comparing groups: 102/88 cm and 94 (90 for
Asian)/80 cm with age as a continuous variable. ORs were also
calculated for 1-SD increases in WC or BMI. Linearity was tested by
addition of squared terms, and ridge regression was used when BMI
and WC were jointly analyzed. Age-, region-, and smoking-adjusted
frequencies of CVD and diabetes mellitus were calculated according
to gender-specific WC tertiles and BMI categories with logistic
regression in SAS PROC GENMOD, with age as a continuous
variable. Trend tests were used to show whether the frequencies of
CVD and diabetes mellitus increased with WC tertiles within each
BMI category, and similarly with BMI categories within each WC
tertile. Age- and region-adjusted ORs for CVD and diabetes mellitus
were also determined for a 1-SD increase in WC within each BMI
category. All statistical analyses used SAS statistical software
(version 8.2; SAS Institute Inc., Cary, NC).
Table 1. Characteristics of Patients in IDEA by Region
Region Countries
No. of
Patients
Mean Age,
y (SD)
Men,
%
Mean Waist Circumference,
cm (SD) Mean BMI, kg/m2 (SD)
Men Women Men Women
Northwestern Europe Austria, Belgium, Denmark, Finland, France,
Germany, Ireland, The Netherlands, Norway,
Sweden, Switzerland
29 582 51.7 (16.4) 43.3 97.8 (13.5) 88.3 (14.8) 27.2 (4.6) 26.4 (5.6)
Southern Europe Greece, Italy, Portugal, Spain, Turkey 31 289 53.0 (15.8) 43.0 99.4 (12.9) 91.3 (14.7) 28.2 (4.5) 27.9 (5.6)
Eastern Europe Bulgaria, Czech Republic, Estonia, Hungary,
Latvia, Lithuania, Poland, Russia, Slovakia,
Slovenia, Ukraine
30 375 50.2 (15.9) 36.8 96.9 (13.7) 89.7 (15.7) 27.5 (4.8) 27.6 (6.0)
Northern Africa Egypt, Morocco, Tunisia 5 028 43.1 (14.7) 37.2 93.6 (15.3) 93.1 (16.2) 26.6 (5.4) 28.3 (6.4)
Southern Africa Republic of South Africa 2 492 42.0 (13.8) 43.2 93.6 (15.5) 89.8 (16.4) 26.9 (5.6) 28.9 (7.2)
Middle East Israel, Kuwait, Lebanon, Qatar, Saudi Arabia,
United Arab Emirates
5 457 41.9 (13.9) 56.0 98.2 (14.2) 93.4 (16.5) 28.2 (5.4) 28.7 (6.9)
Eastern Asia China, Hong Kong, Korea, Taiwan 11 402 48.4 (15.9) 38.6 86.4 (10.7) 80.2 (10.7) 24.4 (4.0) 23.9 (4.1)
Southern Asia India, Indonesia, Malaysia, Pakistan, The
Philippines, Singapore, Thailand, Vietnam
19 381 43.3 (14.7) 50.0 89.3 (13.4) 84.1 (13.9) 24.7 (4.8) 25.0 (5.6)
Australia Australia 1 846 49.3 (16.7) 44.5 99.1 (14.9) 89.0 (15.9) 28.0 (5.2) 27.5 (6.3)
Canada Canada 3 062 51.9 (15.7) 43.8 101.4 (15.2) 92.2 (16.2) 29.2 (5.7) 28.9 (6.9)
Latin America Argentina, Brazil, Chile, Colombia, Dominican
Republic, Ecuador, Guatemala, Jamaica,
Mexico, Peru, Trinidad & Tobago, Venezuela
28 245 44.1 (15.5) 34.4 96.4 (13.4) 89.7 (13.8) 27.8 (4.9) 27.6 (5.7)
Overall 168 159 48.5 (16.1) 41.3 95.8 (14.0) 88.7 (14.9) 27.1 (4.9) 27.0 (5.9)
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The authors had full access to and take full responsibility for the
integrity of the data. All authors have read and agree to the
manuscript as written.
Results
Study Participation
A total of 182 970 patients who attended 6393 PCP offices in
63 countries were screened: 177 345 (97%) agreed to partic-
ipate in the study. Patient (84% to 100%) and physician (4%
to 77%, average 30%) participation is given by country in
the online-only Data Supplement.28 Data were analyzed from
the 95% of patients (69 409 men, 98 750 women) who met
the inclusion criteria and for whom data were available for
age, gender, anthropometric parameters, CVD, and diabetes
mellitus (Table 1). The mean (SD) age was 48.7 (16.1) and
48.3 (16.1) years for men and women.
Distribution of Overweight and Obesity
In all regions except southern and eastern Asia,60% of men
and 50% of women were either overweight or obese
(BMI25 kg/m2). The overall frequency of overweight (BMI
25 to 30 kg/m2) was 40% in men and 30% in women, and this
was remarkably similar across regions (Figure 1). In contrast,
the frequency of obesity (BMI30 kg/m2) differed between
regions and was consistently low in both men and women
in southern and eastern Asia. Obesity ranged from just 7%
in men and women in eastern Asia to 36% in both genders in
Canada, and 38% to 40% in women in the Middle East and
northern and southern Africa.
Distribution of Waist Circumference
A wide distribution of WCs was present within each region,
with median WCs higher in men than in women (Figure 2).
Overall, the median WC (quartiles) was 95 (86 to 104) cm for
men and 88 (78 to 98) cm for women. According to the NCEP
criteria (WC102/88 cm for men/women),29 29% of men and
48% of women had abdominal adiposity; with the IDF
Caucasian criteria (WC94/80 cm for men/women),30 these
frequencies increased to more than half of the population
(men, 56%; women, 71%).
Frequency of CVD and Diabetes Mellitus
According to Region
The overall frequency of CVD was 16% in men and 13% in
women, and was higher in men than in women in all regions
except eastern Asia, with wide variability across regions
Figure 1. Age-standardized frequency of
overweight (BMI 25 to 30 kg/m2) and
obese (BMI30 kg/m2) subjects by
region in (A) men and (B) women.
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(Figure 3). A very high frequency of CVD was present in
Eastern Europe in both men (27%) and women (24%), in
contrast to other regions where frequencies ranged from 8%
(Canadian women) to 16% (northwestern European men).
The frequency of diabetes mellitus showed more regional
variability than CVD (Figure 3). Overall, 13% of men and
11% of women had known diabetes mellitus. Both diabetes
mellitus and CVD were more common in men than women in
all regions except southern Asia. The highest age-
standardized frequency of diabetes mellitus was in the Middle
East (22% in men, 19% in women), followed by northern
Africa (19% and 16%) and southern Asia (17% and 18%).
Relationship Between WC, CVD,
and Diabetes Mellitus
The age- and region-adjusted frequency of CVD increased
with WC in both men and women (Figure 4). Men in the
highest WC quintile (107 cm) had 2.2 more CVD than
those in the lowest quintile (84 cm); for women, when the
most abdominally obese were compared to the least abdom-
inally obese (101 versus 76 cm), the ratio was 2.6.
The frequency of diabetes mellitus showed an even stron-
ger graded increase across the WC quintiles: in men it
increased 3-fold (from 5.7% in the lowest to 19.4% in the
highest WC quintile group) and in women it increased by
almost 6-fold (3.1% to 17.8%) (Figure 4).
The age- and region-adjusted ORs for CVD and diabetes
mellitus according to the NCEP/IDF WC categories are
shown in Table 2.
Relationship Between WC, BMI, and CVD
In men, for all regions except northern Africa and the Middle
East, the OR for CVD associated with a 1-SD increase in WC
was greater than that for a 1-SD increase in BMI (Table 3);
for women, this was the case in all but 4 of the 11 regions.
Overall, the standardized ORs for CVD were higher for WC
than for BMI in both men and women. This was also the case
after adjustment of WC for BMI and of BMI for WC: the ORs
(95% CI) of WC versus BMI were 1.24 (1.19 to 1.28) versus
1.13 (1.09 to 1.17) for men and 1.21 (1.17 to 1.25) versus
1.20 (1.16 to 1.24) for women, which showed that both WC
and BMI were independently associated with CVD.
The frequency of CVD, adjusted for age, region, and
smoking status, increased with WC in each BMI category and
with BMI in each WC tertile (all P0.01) (Figure 5A and
5B). Importantly, CVD was significantly associated with WC
even in lean individuals (BMI25 kg/m2), with standardized
ORs (95% CI) of 1.10 (1.05 to 1.15) in men and 1.15 (1.11 to
1.19) in women, which corresponds to a 9.3-cm increase in
WC in both men and women (Table 4).
Relationship Between WC, BMI,
and Diabetes Mellitus
The standardized ORs for diabetes mellitus (Table 3) were
higher for WC than for BMI in almost all regions, with
overall ORs (95% CI) of 1.59 (1.56 to 1.63) versus 1.52 (1.49
to 1.56) in men and 1.83 (1.79 to 1.87) versus 1.67 (1.64 to
1.71) in women. The exceptions were the Middle East and
Australia, where the ORs for diabetes mellitus were consis-
tently higher for BMI than for WC in both genders. In
northern-African men with diabetes mellitus, the ORs for WC
and BMI were equivalent. After adjustment (WC for BMI and
BMI for WC), WC had a higher OR (95% CI) for diabetes
mellitus than BMI in the overall patient population (men,
1.35 (1.30 to 1.40) versus 1.23 (1.19 to 1.27); women,
1.55(1.50 to 1.60) versus 1.23(1.19 to 1.27)); thus, both WC
and BMI were independently associated with diabetes melli-
Table 2. Age- and Region-Adjusted ORs for CVD and Diabetes
Mellitus According to the NCEP/IDF WC Categories
OR (95% CI)
for CVD
OR (95% CI) for
Diabetes Mellitus
WC for men
94 cm 1 1
94 to 102 cm (90 to 102 cm
for Asians)
1.28 (1.21 to 1.36) 1.60 (1.51 to 1.71)
102 cm 1.90 (1.80 to 2.02) 2.65 (2.49 to 2.81)
WC for women
80 cm 1 1
80 to 88 cm 1.31 (1.22 to 1.41) 1.78 (1.64 to 1.94)
88 cm 1.97 (1.85 to 2.09) 3.94 (3.66 to 4.24)
Figure 2. Box-and-whisker plots show the distribution of WC by
region for (A) men and (B) women. Data shown are medians,
quartiles, and 2.5 and 97.5 percentiles. Vertical lines show
WC102 cm (men) and WC88 cm (women).
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tus. Furthermore, both WC and BMI were more strongly
associated with diabetes mellitus than with CVD, particularly
in women (Table 3).
Diabetes mellitus frequency, adjusted for age, region, and
smoking status, increased with WC tertiles within each BMI
category, and with BMI categories within each WC tertile (all
P0.01) (Figure 5C and 5D). Diabetes mellitus was signifi-
cantly associated with WC even in lean individuals (BMI25
kg/m2); for a 9.3-cm increase in WC, the standardized ORs
(95% CI) were 1.27 (1.21 to 1.33) in men and 1.43 (1.37 to
1.48) in women (Table 4).
Discussion
IDEA is the largest study to assess the frequency of adiposity
in primary care patients: nearly 170 000 ambulant patients
from 63 countries across 5 continents were studied to provide
a snapshot of patients worldwide. The study results show that
excess body weight is pandemic (apart from southern and
eastern Asia), with one half to two thirds of the population
overweight or obese by current definitions. Abdominal obe-
sity, measured by WC, showed a graded relationship with
both CVD and diabetes mellitus at all levels of BMI,
importantly even in so-called lean subjects. These relation-
ships were consistent across regions for both men and
women, despite the up to 3-fold difference in background
frequency of CVD and diabetes mellitus between regions.
Our findings support the need for worldwide population-
based initiatives to target adiposity. If improvements are not
forthcoming, recent favorable trends in cardiovascular mor-
bidity and mortality are likely to be reversed.
Comparisons With Other Studies
In the present study, the ranking of regional frequencies of
both CVD and diabetes mellitus from patients in primary care
are consistent with other published data. In Eastern Europe,
CVD mortality rates are very high31 for both men and women,
and the frequency of diabetes mellitus in the Middle East and
northern Africa is known to be high and increasing.32 Patterns
of adiposity contribute to these geographic variations in
disease, but other genetic, environmental, and behavioral
characteristics are also clearly important.
The findings of IDEA, which associated WC with diabetes
mellitus and with all stages of CVD, extend those from the
INTERHEART study, which involved only myocardial in-
farction.15,16 It is likely that early intervention to target
adiposity would have the greatest impact on lifetime mani-
Figure 3. Age-standardized frequencies
of (A) CVD and (B) diabetes mellitus by
region in men and women.
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festations of diabetes mellitus and atherosclerosis. The
greater impact of WC compared with BMI on diabetes
mellitus is consistent with prospective studies in American
men (the Health Professionals’ Follow-Up Study22) and
women (the Nurses Health Study19). These studies also
showed that WC was a better predictor of diabetes mellitus
than the waist:hip ratio. These epidemiological data are
supported by animal and human reports of differences in
subcutaneous and visceral fat phenotype, with visceral fat
associated with inflammation, unfavorable adipokine
profiles, and disturbances of insulin and glucose
homeostasis.33,34
The mechanisms by which abdominal adiposity may lead
to clinical disease are not clarified by the findings of the
IDEA study. Two new, large-scale, multinational studies
(International Study of Prediction of Intra-Abdominal Adi-
posity and its Relationships With Cardiometabolic Risk
[INSPIRE ME] and INSPIRE ME IAA [Intra-Abdominal
Adiposity study]) that will involve detailed profiling of risk
factors, inflammatory biomarkers, as well as computed to-
mography to quantify visceral fat have been initiated. Previ-
ous small-scale studies that used computed tomography have
shown very strong associations between intraabdominal fat
and the development of CVD and diabetes mellitus in
Japanese-Americans who are not obese but are at high risk for
development of diabetes mellitus.21,35
Strengths and Limitations
The IDEA Study was very large and covered most regions of
the world. Particular care was taken with the random selec-
tion of PCPs to ensure that the physicians, and consequently
their patients, were representative within each geographic
area of each country. The study population included all
patients who consulted their PCPs, with only 2 exclusion
criteria: age 18 or 80 years and pregnancy. Patient
participation was high, but in some countries the PCP
participation was low; when contacted, the PCPs either did
not answer the call or refused to participate for different
reasons (“Not interested”; “Not available on target days”;
“No time to participate”). This may affect the reported
frequencies and associations, but it is not possible to deter-
mine the extent and direction of any bias this might cause.
The present study was conducted in primary care, as this
was a feasible way to recruit large numbers of individuals in
each country; the response rate was 97%, even though
patients were not remunerated. Results cannot be extrapolated
to the general population of the countries, only to the
population that consults PCPs.
Figure 4. Age- and region-adjusted frequencies
of CVD and diabetes mellitus across gender-
specific quintiles of WC in the overall study
population of (A) men (n69 409) and (B)
women (n98 750).
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An important strength of IDEA was the uniform documen-
tation, translated into the various languages, and the physi-
cians’ training to measure WC with a standardized approach.1
In the present study, we chose to use WC as a measure of
abdominal adiposity because a close correlation between WC
and the amount of intraabdominal fat has been observed with
computed tomography.36 In addition, WC requires only a
single measurement, which makes it easier, less time con-
suming, and less subject to error than measurements that
combine waist and hip measurements for the waist:hip ratio.
Intra- and interphysician variability in WC measurement was
not formally assessed. Despite possible measurement error,
clear relationships were shown between WC and both CVD
and diabetes mellitus. Furthermore, the relationship was
stronger in most cases for WC than BMI, even though the
latter should have less measurement error.
Physician-reported diagnosis is probably more reliable
than patient-reported diagnosis.19 In our study no diagnostic
procedure was carried out either for diabetes mellitus or CVD
(defined as coronary heart disease, stroke, or revasculariza-
tion). The relationships were clear despite the potentially
different definitions used in clinical practice between regions
for both conditions. The IDEA questionnaire did not distin-
guish between type 1 and type 2 diabetes mellitus. Because
the majority of patients with diabetes mellitus (85% to 95%)
have type 2 diabetes mellitus,32 the observed relationships
between diabetes mellitus and adiposity would be primarily
driven by type 2 diabetes mellitus.
It was not possible to determine whether the relationships
between WC and CVD or diabetes mellitus differed across
ethnic groups within geographic regions, because race was
not recorded in IDEA as a result of legal restrictions in some
countries. Race within regions may have an impact on the risk
of CVD and diabetes mellitus associated with WC, as
suggested by INTERHEART,16 but race is difficult to docu-
ment accurately.
Conclusions
IDEA showed that the frequency of adiposity is high in all
regions of the world, even in Asian populations that are
usually considered to be lean. The regional frequencies of
overweight were surprisingly similar, but regional differences
were present in the frequency of obesity. The lower levels of
marked adiposity in regions such as southern and eastern Asia
Table 3. Age-Adjusted, Standardized ORs for CVD and Diabetes in Men and Women Associated With a 1-SD Increase in WC or BMI,
by Region
Age-Adjusted ORs (95% CI) for CVD Associated With a 1-SD Increase in WC or BMI
Men Women
WC BMI WC BMI
Northwestern Europe 1.29 (1.23 to 1.36)* 1.27 (1.21 to 1.33)* 1.37 (1.30 to 1.44)* 1.31 (1.24 to 1.37)*
Southern Europe 1.31 (1.25 to 1.38)* 1.22 (1.17 to 1.28)* 1.30 (1.23 to 1.37)* 1.22 (1.16 to 1.28)*
Eastern Europe 1.42 (1.35 to 1.49)* 1.41 (1.34 to 1.48)* 1.48 (1.42 to 1.54)* 1.53 (1.47 to 1.59)*
Northern Africa 1.48 (1.25 to 1.74)* 1.51 (1.30 to 1.77)* 1.50 (1.28 to 1.75)* 1.52 (1.32 to 1.74)*
Southern Africa 1.93 (1.49 to 2.50)* 1.63 (1.29 to 2.06)* 1.51 (1.19 to 1.92)† 1.43 (1.11 to 1.84)‡
Middle East 1.44 (1.25 to 1.66)* 1.49 (1.30 to 1.70)* 1.51 (1.28 to 1.79)* 1.52 (1.29 to 1.78)*
Eastern Asia 1.33 (1.21 to 1.47)* 1.32 (1.20 to 1.46)* 1.32 (1.22 to 1.44)* 1.21 (1.12 to 1.30)*
Southern Asia 1.27 (1.18 to 1.36)* 1.26 (1.17 to 1.35)* 1.30 (1.21 to 1.39)* 1.26 (1.18 to 1.35)*
Australia 1.76 (1.39 to 2.22)* 1.53 (1.24 to 1.89)* 1.19 (0.95 to 1.50) 1.11 (0.87 to 1.40)
Canada 1.26 (1.08 to 1.47)‡ 1.19 (1.03 to 1.39)§ 1.50 (1.25 to 1.81)* 1.49 (1.25 to 1.77)*
Latin America 1.28 (1.19 to 1.38)* 1.23 (1.15 to 1.32)* 1.36 (1.28 to 1.44)* 1.37 (1.29 to 1.44)*
Overall 1.36 (1.33 to 1.39)* 1.32 (1.29 to 1.35)* 1.40 (1.37 to 1.43)* 1.38 (1.35 to 1.41)*
(Continued)
See Table 1 for SDs by region and overall. Overall data are also adjusted for region.
*P0.0001; †P0.001; ‡P0.01; §P0.05.
Table 4. Age- and Region-Adjusted Standardized ORs (95% CI) for CVD and Diabetes Mellitus in Men and Women Associated With a
1-SD Increase in WC by BMI Categories
BMI Category
Men Women
1 SD WC (cm)
OR (95% CI)
for CVD
OR (95% CI) for
Diabetes Mellitus 1 SD WC (cm)
OR (95% CI)
for CVD
OR (95% CI) for
Diabetes Mellitus
BMI25 kg/m2 9.3 1.10 (1.05 to 1.15)* 1.27 (1.21 to 1.33)* 9.3 1.15 (1.11 to 1.19)* 1.43 (1.37 to 1.48)*
BMI 25 to 30 kg/m2 8.5 1.19 (1.15 to 1.23)* 1.23 (1.18 to 1.27)* 9.2 1.12 (1.08 to 1.16)* 1.32 (1.27 to 1.37)*
BMI30 kg/m2 11.4 1.23 (1.18 to 1.28)* 1.34 (1.29 to 1.39)* 11.9 1.24 (1.20 to 1.29)* 1.43 (1.38 to 1.47)*
Overall 14.0 1.36 (1.33 to 1.39)* 1.59 (1.56 to 1.63)* 14.9 1.40 (1.37 to 1.43)* 1.83 (1.79 to 1.87)*
*P0.0001.
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are not necessarily reassuring, as the impact of adiposity—
particularly abdominal adiposity—is rising and may be more
acute in certain populations. IDEA emphasizes the need for a
global approach to adiposity from early in life. Adiposity in
teenagers is rapidly increasing and is associated with adverse
changes in arterial wall structure and function, the early
stages of atherosclerosis.37 The Diabetes Prevention Program
has shown the beneficial effects of weight reduction,38 and
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Figure 5. Frequency of known CVD for men (A) and women (B), and known diabetes mellitus for men (C) and women (D), adjusted for
age, region, and smoking status, by gender-specific WC tertiles and BMI categories. The percentage of patients in each of the 9
groups is shown.
Table 3. Continued
Age-Adjusted ORs (95% CI) for Diabetes Mellitus Associated With a 1-SD Increase in WC or BMI
Men Women
WC BMI WC BMI
1.76 (1.67 to 1.86)* 1.72 (1.63 to 1.81)* 2.17 (2.05 to 2.29)* 1.96 (1.86 to 2.06)*
1.45 (1.38 to 1.53)* 1.39 (1.33 to 1.46)* 1.78 (1.69 to 1.87)* 1.68 (1.60 to 1.76)*
1.83 (1.72 to 1.95)* 1.73 (1.63 to 1.83)* 1.98 (1.88 to 2.09)* 1.82 (1.73 to 1.91)*
1.57 (1.38 to 1.79)* 1.57 (1.38 to 1.78)* 1.63 (1.46 to 1.82)* 1.44 (1.30 to 1.60)*
1.71 (1.38 to 2.11)* 1.52 (1.25 to 1.85)* 1.89 (1.52 to 2.34)* 1.70 (1.38 to 2.09)*
1.35 (1.22 to 1.50)* 1.40 (1.27 to 1.54)* 1.86 (1.64 to 2.11)* 1.89 (1.68 to 2.12)*
1.38 (1.25 to 1.51)* 1.25 (1.14 to 1.37)* 1.45 (1.33 to 1.57)* 1.32 (1.23 to 1.43)*
1.53 (1.44 to 1.62)* 1.43 (1.35 to 1.51)* 1.57 (1.47 to 1.67)* 1.41 (1.33 to 1.50)*
1.49 (1.20 to 1.85)† 1.50 (1.22 to 1.83)† 1.45 (1.20 to 1.75)† 1.54 (1.28 to 1.86)*
1.92 (1.65 to 2.23)* 1.81 (1.57 to 2.09)* 2.40 (2.06 to 2.80)* 2.02 (1.76 to 2.32)*
136 (1.27 to 1.46)* 1.34 (1.26 to 1.43)* 1.66 (1.57 to 1.75)* 1.51 (1.44 to 1.59)*
1.59 (1.56 to 1.63)* 1.52 (1.49 to 1.56)* 1.83 (1.79 to 1.87)* 1.67 (1.64 to 1.71)*
Balkau et al Waist Circumference, CVD, and Diabetes 1949
 by guest on M
arch 29, 2018
http://circ.ahajournals.org/
D
ow
nloaded from
 
objective measures of improvements in the arterial wall can
be rapidly identified after lifestyle modifications, such as diet
and physical exercise, in the young.39
IDEA has already increased global awareness of abdomi-
nal adiposity among PCPs, but the importance of this risk
factor remains inadequately recognized. Routine measure-
ment of WC—a convenient and inexpensive measure in
primary care—provides a clinical marker for risk of CVD and
diabetes mellitus in all regions of the world, even in patients
with normal weight. The rise in adiposity worldwide is likely
to contribute to major increases in morbidity and mortality
from diabetes mellitus and CVD unless it can be adequately
addressed by public health programs.
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CLINICAL PERSPECTIVE
The INTERHEART case-control study has highlighted the importance of adiposity, particularly central adiposity, for
myocardial infarction. In the International Day for the Evaluation of Abdominal Obesity (IDEA) study of 170 000
consecutive patients who consulted randomly chosen primary care physicians in 63 countries, the frequency of overweight
patients (body mass index (BMI) between 25 and 30 kg/m2) was similar across geographical regions (40% men, 30%
women), in contrast to obesity (24% men, 27% women), which was lowest in southern and eastern Asia, highest for men
in southern Europe, the Middle East, and Canada, and highest for women in southern and northern Africa and the Middle
East. Regional trends were similar for high waist circumference. Previously diagnosed cardiovascular disease and
previously diagnosed diabetes mellitus were both associated with a high waist circumference, and each additional
centimeter increased risk, even after accounting for BMI. The relations were stronger for diabetes mellitus. Overall and in
most regions, the associations with waist circumference were stronger than with BMI. For men, a waist circumference
102 cm in comparison to 94 cm (90 cm for Asian men) carried an odds ratio of 1.90 for cardiovascular disease and
2.65 for diabetes mellitus; for women, a waist circumference 88 cm in comparison to 80 cm carried an odds ratios of
1.97 for cardiovascular disease and 3.94 for diabetes mellitus. The waist circumference should be measured—in addition
to the BMI—in clinical practice because it is associated with prevalent cardiovascular disease (not just myocardial
infarction) and with prevalent diabetes mellitus, even in the so-called lean populations with BMI25 kg/m2.
Go to http://cme.ahajournals.org to take the CME quiz for this article.
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